Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Burkitt Lymphoma × liposomal doxorubicin × Clear all

Phase

Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 23 Fallopian Tube Neoplasms 12 Breast Neoplasms 11 Neoplasms 10 Triple Negative Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Solid Tumors 4 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Sarcoma 3 Lymphoma 3 Carcinoma 3 Sarcoma, Kaposi 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 AIDS-related Kaposi sarcoma 2 Urinary Bladder Neoplasms 1 Unrecognized Condition 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1

Interventions

Cyclophosphamide 42 Filgrastim 20 Rituximab 19 Etoposide 18 fludarabine phosphate 16 Prednisone 16 Vincristine 15 Peripheral Blood Stem Cell Transplantation 14 fludarabine 13 Doxorubicin 11 Cytarabine 10 Methotrexate 8 Cyclosporine 8 venetoclax 7 blinatumomab 7 Vorinostat 7 Paclitaxel 7 Lenalidomide 7 Melphalan 6 Dexamethasone 6 Biopsy 6 tanespimycin 5 aldesleukin 5 Radiotherapy 5 Inotuzumab Ozogamicin 5 Indium 5 Dasatinib 5 Calcium Dobesilate 5 Bortezomib 5 ibrutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05270057 2025-10-09

LONCA

Medical College of Wisconsin

Phase 1 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡